Problems of thrombolytic therapy.
Neilson
R F
RF
Department of Haematology, Glasgow Royal Infirmary, UK.
Davidson
J F
JF
D003328:Coronary Thrombosis / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D013300:Streptokinase / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator